Budesonide in Patients With Immune Mediated Enteropathies

PHASE4TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 10, 2019

Primary Completion Date

October 19, 2021

Study Completion Date

October 19, 2021

Conditions

EnteropathyCeliac DiseaseCVID EnteropathyCollagenous SprueAutoimmune Enteropathy

Interventions

DRUG

Withdrawal of Oral Budesonide

The intervention arm will taper and stop budesonide therapy (withdrawal).

Trial Locations (1)

Mayo Clinic in Rochester, Rochester